Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 48 | $141,249,305 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 47 | 805.55 | 37,861 | I |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 53 | 984.02 | 52,153 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 122 | 801.16 | 97,742 | I |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 111 | 965.69 | 107,192 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 120 | 989.14 | 118,697 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 182 | 987.38 | 179,703 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 254 | 800.59 | 203,350 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 254 | 804.38 | 204,313 | I |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 303 | 982.29 | 297,634 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 400 | 810.3 | 324,120 | I |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 373 | 988.36 | 368,658 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 379 | 978.18 | 370,730 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 406 | 971.28 | 394,340 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 442 | 986.4 | 435,989 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 504 | 979.87 | 493,854 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 642 | 803.3 | 515,719 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 700 | 806.47 | 564,529 | I |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 647 | 985.62 | 637,696 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 727 | 983.88 | 715,281 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 782 | 966.29 | 755,639 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 784 | 972.5 | 762,440 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 790 | 972.22 | 768,054 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 846 | 970.36 | 820,925 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 907 | 967.4 | 877,432 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 1,237 | 802.54 | 992,742 | I |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 1,227 | 977.38 | 1,199,245 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,223 | 980.72 | 1,199,421 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,428 | 967.45 | 1,381,519 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,865 | 973.43 | 1,815,447 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,930 | 969.14 | 1,870,440 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 2,283 | 981.52 | 2,240,810 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 2,653 | 973.8 | 2,583,491 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 3,213 | 968.44 | 3,111,598 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 3,387 | 968.43 | 3,280,072 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 4,669 | 970.26 | 4,530,144 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 4,778 | 974.47 | 4,656,018 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 4,865 | 978.44 | 4,760,111 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 4,886 | 976.52 | 4,771,277 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 4,922 | 971.56 | 4,782,018 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 5,225 | 975.6 | 5,097,510 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 6,885 | 976.56 | 6,723,616 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 7,611 | 974.51 | 7,416,996 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 9,242 | 975.48 | 9,015,386 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 9,501 | 969.39 | 9,210,174 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 9,851 | 977.42 | 9,628,564 | D |
08 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 06 Feb 2023 | Sale | 13,189 | 800.08 | 10,552,255 | I |
04 Jan 2024 16:20 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 02 Jan 2024 | Sale | 16,848 | 900 | 15,163,200 | I |
01 May 2024 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 02 Jan 2024 | Sale | 16,848 | 900 | 15,163,200 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)